310P Clinical characteristics and real-world progression-free survival of patients with EGFR mutation positive non-small cell lung cancer treated with afatinib as first-line: A retrospective cohort study from Indonesia.

Autor:	Soeroso, N.N.1 (AUTHOR), Syahruddin, E.2 (AUTHOR)
Zdroj:	Annals of Oncology. Nov2022 Suppl 9, Vol. 33, pS1555-S1556. 2p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu